Haemorrhagic shock in the dog. The formation of thromboemboli during antifibrinolytic therapy.
D000818:Animals; D001792:Blood Platelets; D003509:Cyclohexanecarboxylic Acids / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced*; D004285:Dogs; D005260:Female; D005337:Fibrin; D005342:Fibrinolysis / Q000187:drug effects; D007422:Intestines / Q000473:pathology; D007668:Kidney / Q000473:pathology; D008099:Liver / Q000473:pathology; D008168:Lung / Q000473:pathology; D008297:Male; D010179:Pancreas / Q000473:pathology; D011169:Portal Vein / Q000473:pathology; D012771:Shock, Hemorrhagic / Q000188:drug therapy* / Q000473:pathology; D013154:Spleen / Q000473:pathology; D013923:Thromboembolism / Q000139:chemically induced / Q000473:pathology; D013924:Thrombophlebitis / Q000473:pathology
D003509:Cyclohexanecarboxylic Acids; D005337:Fibrin